Related Experiment Video
Updated: Apr 30, 2026
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Animal models of Epstein Barr virus infection
Bithi Chatterjee1, Carol Sze Leung1, Christian Münz1
1Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Switzerland.
Abstract:
Epstein Barr virus (EBV) was the first human tumor virus to be identified. Despite 50years of research on this oncogenic virus, no therapeutic or prophylactic vaccine is available against this pathogen. In part, the development of such a vaccine is hampered by the lack of in vivo models for EBV infection and immune control. However, with the advent of mice with reconstituted human immune system components (HIS mice), certain aspects of EBV associated diseases and immune responses can be modeled in vivo. In this review, we will discuss the insights that can be gained from these experiments, and how immune system components can be manipulated to interrogate their function during EBV infection. Finally, we will compare EBV immunobiology in HIS mice to infection by EBV-related viruses in monkeys, and we will outline the strengths and weaknesses of these two in vivo models of EBV infection. Both of these models show great promise as a platform for preclinical EBV vaccine testing.
Insights
Developing a vaccine for Epstein-Barr virus (EBV) is challenging due to limited in vivo models. Human immune system (HIS) mice offer a promising preclinical platform for EBV vaccine testing and studying immune responses.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Epstein-Barr virus (EBV) is the first identified human tumor virus.
- Despite extensive research, effective vaccines against EBV are still unavailable.
- Lack of suitable in vivo models hinders EBV vaccine development and immune response studies.
Purpose of the Study:
- To review insights gained from human immune system (HIS) mice models for EBV infection.
- To discuss manipulation of immune components for interrogating EBV infection dynamics.
- To compare HIS mice models with non-human primate models for EBV-related virus infections.
Main Methods:
- Review of studies utilizing HIS mice to model EBV infection and immune responses.
- Analysis of experimental approaches for manipulating immune system components in HIS mice.
- Comparative evaluation of HIS mice and non-human primate models for EBV research.
Main Results:
- HIS mice allow in vivo modeling of EBV-associated diseases and immune control.
- Manipulation of immune components in HIS mice aids in understanding EBV infection.
- Both HIS mice and non-human primate models offer valuable platforms for EBV research.
Conclusions:
- HIS mice represent a significant advancement for in vivo EBV research.
- These models are crucial for preclinical testing of EBV vaccines.
- Further research comparing HIS mice and non-human primate models will refine EBV infection studies.
